Author

Shankar Swaminathan

Unknown affiliation - Cited by 1,443 - Drug delivery - pharmacokinetics - targeting - gene mining using systems genetics in eye diseases - Nanosponges

Biography

He is a pharmaceutical scientist and polymer chemist turned into an eye/vision researcher. He received his Ph.D. in Pharmaceutics from the Institute of Chemical Technology, India. He was also a research assistant at the University of Turin, Italy during his Ph.D. He went on to gain research experience in the industry after his Ph.D. specializing in long acting polymeric medical devices for contraception where he was instrumental in getting the product to the scale up stage. Currently, a postdoctoral researcher at the University of Tennessee Health Science Center.
Title
Cited by
Year
Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity
S Swaminathan, L Pastero, L Serpe, F Trotta, P Vavia, D Aquilano, ...European Journal of Pharmaceutics and Biopharmaceutics 74 (2), 193-201, 2010201
363
2010
Formulation of betacyclodextrin based nanosponges of itraconazole
S Swaminathan, PR Vavia, F Trotta, S TorneJournal of inclusion phenomena and macrocyclic chemistry 57, 89-94, 2007200
205
2007
Cyclodextrin‐based nanosponges: a versatile platform for cancer nanotherapeutics development
S Swaminathan, R Cavalli, F TrottaWiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 8 (4 …, 2016201
144
2016
Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery
L Battaglia, PP Panciani, E Muntoni, MT Capucchio, E Biasibetti, ...Expert opinion on drug delivery 15 (4), 369-378, 2018201
117
2018
In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin
S Swaminathan, R Cavalli, F Trotta, P Ferruti, E Ranucci, I Gerges, ...Journal of inclusion phenomena and macrocyclic chemistry 68, 183-191, 2010201
103
2010
Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment
S Swaminathan, PR Vavia, F Trotta, R CavalliJournal of biomedical nanotechnology 9 (6), 998-1007, 2013201
79
2013
Structural evidence of differential forms of nanosponges of beta-cyclodextrin and its effect on solubilization of a model drug
S Swaminathan, PR Vavia, F Trotta, R Cavalli, S Tumbiolo, L Bertinetti, ...Journal of Inclusion Phenomena and Macrocyclic Chemistry, 1-11, 2012201
79
2012
Applications of nanosponges in drug delivery
PR Vavia, S Swaminathan, F Trotta, R CavalliProceedings XIII International Cyclodextrin Symposium, 14-17, 2006200
31
2006
Genetic Modulation of the Iris Transillumination Defect: A Systems Genetics Analysis using the Expanded Family of BXD Glaucoma Strains
S Swaminathan, H Lu, RW Williams, L Lu, MM JablonskiPigment Cell & Melanoma Research, 131
20
2013
Cyclodextrin-based nanohydrogels containing polyamidoamine units: a new dexamethasone delivery system for inflammatory diseases
M Argenziano, C Dianzani, B Ferrara, S Swaminathan, A Manfredi, ...Gels 3 (2), 22, 202
17
2017
Proline-catalysed asymmetric annelations: a novel observation
N Ramamurthi, S SwaminathanIndian Journal of Chemistry 29 (5), 401-404, 1990199
16
1990
Soluble Itraconazole in Tablet Form Using Disordered Drug Delivery Approach: Critical Scale-up Considerations and Bio-equivalence Studies
S Swaminathan, M Sangwai, S Wawdhane, P VaviaAAPS PharmSciTech, doi10.1208/s12249-012-991, 2013201
15
2013
Release modulation and conformational stabilization of a model protein by use of swellable nanosponges of betacyclodextrin
S Swaminathan, P Vavia, F Trotta, R Cavalli, P Ferruti, E Ranucci, ...First European Cyclodextrin conference, Aalborg, Denmark, 20020
9
2009
Novel functionalized nanosponges: synthesis, characterization. Safety assessment, cytotoxicity testing and interaction studies
F Trotta, R Cavalli, S Swaminathan, C Sarzanini, P VaviaProceedings of the 14th International Cyclodextrin Symposium, Kyoto, 338-342, 2008200
7
2008
"Studies on novel dosage forms."
S Swaminathan" Masters of pharmaceutical Sciences Dissertation submitted to the …, 2006200
7
2006
Cyclodextrin nanosponges
S Swaminathan, F TrottaNanosponges: Synthesis and Applications, 27-57, 2019201
6
2019
Novel Endogenous Glycan Therapy for Retinal Diseases: Safety, In Vitro Stability, Ocular Pharmacokinetic Modeling, and Biodistribution
S Swaminathan, H Li, M Palamoor, WT Luchsinger de Obarrio, ...AAPS Journal, 20120
4
2014
"Design and characterization of novel polymeric drug delivery system."
S Swaminathan"Ph. D.(Tech.) Dissertation submitted to the University of Mumbai, 2010.", 2010201
4
2010
Non-Biological Membranes as Drug Delivery Systems
S Swaminathan, MM JablonskiJournal of Membrane Science & Technology 2 (), 2012201
3
2012
Novel functionalized beta cyclodextrin nanosponge based stable formulation of camptothecin and in vitro cytotoxicity evaluation.
S Swaminathan, PR Vavia, F Trotta, R Cavalli, L Serpe, Zara, G. P.A poster presented at the Fifth Asian cyclodextrin conference in Busan. Korea, 2009200
3
2009

Referred From: https://scholar.google.com/citations?user=RjMRo3EAAAAJ&hl=fr

Cited by
Citations 1443
h-index 14
i10-index 14
Recommended Journals
Open Access Journals